Free Trial

Merrimack Pharmaceuticals (MACK) Earnings Date, Estimates & Call Transcripts

Notice: This company has been marked as potentially delisted and may not be actively trading.

Earnings Summary

Upcoming
Earnings Date
Aug. 1Estimated
Actual EPS
(May. 15)
-$0.03 Missed By -$0.03
Skip Charts & View Estimated and Actual Earnings Data

MACK Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

MACK Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

MACK Earnings Date and Information

Merrimack Pharmaceuticals last released its earnings results on May 15th, 2024. The biopharmaceutical company reported ($0.03) earnings per share for the quarter. Merrimack Pharmaceuticals has generated $13.87 earnings per share over the last year ($13.87 diluted earnings per share) and currently has a price-to-earnings ratio of 1.1. Merrimack Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 1st, 2024 based off prior year's report dates.

Merrimack Pharmaceuticals Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
8/1/2024
(Estimated)
------- 
5/15/2024Q1 2024-($0.03)($0.03)($13.99)--
3/7/2024Q4 2023-($0.01)($0.01)($0.01)--
11/2/2023Q3 2023-($0.02)($0.02)($0.02)--
8/3/2023Q2 2023-($0.03)($0.03)($0.03)--
5/4/2023Q1 2023-($0.02)($0.02)($0.02)--
3/9/2023Q4 2022-($0.03)($0.03)($0.03)--
11/3/2022Q3 2022-($0.03)($0.03)($0.03)--
8/4/2022Q2 2022-($0.04)($0.04)($0.04)--
5/5/2022Q1 2022-($0.04)($0.04)($0.07)--
3/9/2022Q4 2021-($0.03)($0.03)($0.03)--
11/4/2021Q3 2021-($0.04)($0.04)($0.04)--
8/5/2021Q2 2021-($0.06)($0.06)($0.06)--
5/6/2021Q1 2021-($0.05)($0.05)($0.05)--
3/10/2021Q4 2020-($0.08)($0.08)($0.08)--
11/5/2020Q3 2020-($0.08)($0.08)($0.08)--
8/7/2020Q2 2020-($0.09)($0.09)($0.09)--
5/7/2020Q1 2020-$0.02+$0.02$0.02--
11/12/2019Q3 2019-($0.05)($0.05)($0.05)--

Merrimack Pharmaceuticals Earnings - Frequently Asked Questions

When is Merrimack Pharmaceuticals's earnings date?

Merrimack Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 1st, 2024 based off last year's report dates. Learn more on MACK's earnings history.

How much profit does Merrimack Pharmaceuticals generate each year?

Merrimack Pharmaceuticals (NASDAQ:MACK) has a recorded net income of -$1.18 million. MACK has generated $13.87 earnings per share over the last four quarters.

What is Merrimack Pharmaceuticals's price-to-earnings ratio?

Merrimack Pharmaceuticals (NASDAQ:MACK) has a trailing price-to-earnings ratio of 1.09.


More Earnings Resources from MarketBeat

This page (NASDAQ:MACK) was last updated on 7/19/2024 by MarketBeat.com Staff

From Our Partners